Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Kronox Lab Sciences Ltd. shows no growth metrics and poor profitability indicators compared to its peers, making it a significant underperformer in the chemicals sector. It lacks revenue and earnings growth, indicating potential operational challenges and limited market competitiveness.
Strong revenue growth (6.12% YoY) and high profitability (ROE of 22.45%).
High ROE (29.59%) and EPS growth of 133.65, despite recent revenue decline.
Good balance of profitability (ROE of 12.27%) and growth (11.83% revenue growth YoY).